Aclipse Therapeutics
Aclipse Therapeutics is focused on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel drug molecule that inhibits these pathways, allowing us to build upon existing nonclinical and clinical data while creating a significant patent barrier-to-entry.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
10
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Aclipse Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- BM
Brian Moyer
Vice President, Corporate Development and Finance · Other
EmailPhone - MK
Michael Kranda
Board Member, Chief Business Officer · General Business & Management
EmailPhone - MK
Michael Kranda
Board Member, Chief Business Officer · General Business & Management
EmailPhone - NS
Ning Shan
Chief Scientific Officer and Co-founder · Science
EmailPhone
Showing 4 of 6 verified contacts
Top roles at Aclipse Therapeutics
5 distinct titles indexed · top 5 shown.
- 2board member, chief business officer
- 1chair of the board of directors
- 1chief scientific officer and co-founder
- 1project development manager
- 1vice president, corporate development and finance
Sign up to unlock all 6 contacts at Aclipse Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Aclipse Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.